年龄相关性黄斑变性的潜在治疗靶点:核受体选项
本文综述核受体在眼后极部细胞中的高表达及其在衰老和年龄相关性黄斑变性(AMD)中的作用,提出眼是次级内分泌器官的假说,并讨论靶向这些核受体治疗AMD的潜力,指出超过85%的AMD患者缺乏治疗选择。
要点
- 核受体在眼后极部细胞(包括视网膜色素上皮和脉络膜内皮细胞)中高表达。
- 眼可能作为次级内分泌器官,核受体为AMD易感细胞的生物学过程提供基础。
- 超过85%的AMD患者缺乏治疗选择,靶向核受体信号通路具有治疗潜力。
核心结论
- 综述支持眼是次级内分泌器官的假说,其中核受体为AMD易感细胞(包括视网膜色素上皮和脉络膜内皮细胞)的生物学过程提供基础,并讨论靶向这些受体治疗AMD的潜力。
研究设计与样本
- 综述类文章,检索范围原文未报告。
主要发现
- 近期研究显示核受体在眼后极部细胞中高表达。
- 核受体参与发育和衰老过程中的多种生理功能,包括细胞稳态和代谢。
- 超过85%的AMD患者缺乏治疗选择。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The functions and activities of nuclear receptors, the largest family of transcription factors in the human genome, have classically focused on their ability to act as steroid and hormone sensors in endocrine organs. However, they are responsible for a diverse array of physiological functions, including cellular homeostasis and metabolism, during development and aging. Though the eye is not a traditional endocrine organ, recent studies have revealed high expression levels of nuclear receptors in cells throughout the posterior pole. These findings have precipitated an interest in investigating the role of these transcription factors in the eye as a function of age and ocular disease, in particular age-related macular degeneration (AMD). As the leading cause of vision impairment in the elderly, identifying signaling pathways that may be targeted for AMD therapy is of great importance, given the lack of therapeutic options for over 85% of patients with this disease. Herein we review this relatively new field and recent findings supporting the hypothesis that the eye is a secondary endocrine organ, in which nuclear receptors serve as the bedrock for biological processes in cells vulnerable in AMD, including retinal pigment epithelial and choroidal endothelial cells, and discuss the therapeutic potential of targeting these receptors for AMD.
引用
- Choudhary M, Malek G. Potential therapeutic targets for age-related macular degeneration: The nuclear option. Prog Retin Eye Res. 2022. PMID: 36220751. doi:10.1016/j.preteyeres.2022.101130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。